The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI-nexus Global. Regulatory News (INX)

Share Price Information for I-nexus Global. (INX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.00
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.50 (16.667%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
INX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

27 Mar 2020 15:11

RNS Number : 9229H
i-nexus Global PLC
27 March 2020
 

i-nexus Global plc

("i-nexus", the "Company" or the "Group")

 

Business Update

i-nexus Global plc (AIM: INX), a provider of cloud-based Strategy Execution software solutions for the Global 5000, today provides a business update in light of the global COVID-19 pandemic.

The health and safety of our staff is our top priority. As with many software companies, we are an agile business and well-equipped to facilitate remote working. Our staff have been working from home since March 20th, with no disruption to the Company's continuity of service.

As the temporary global shutdown and associated uncertainty continues, the Group is experiencing longer sales cycles as existing and potential customers focus on business continuity planning and postpone procurement decisions for new software. This is currently making it increasingly difficult to forecast future sales. In addition, as our clients' businesses are impacted, they are inevitably looking to conserve cash, with consequential uncertainty for i-nexus regarding the timing of collection of our debtors although every effort is being made to secure timely settlement.

The Board has been monitoring this evolving situation very closely and given the level of uncertainty, it has resolved to undertake material, short-term measures to mitigate the impact of COVID-19 on financial performance to the extent possible. This includes salary sacrifices across the Company, together with general overhead reductions, staffing cuts and the 'furloughing' of a proportion of the workforce under the Government's recently announced 'Job Retention Scheme'. As at 29 February 2020, the Company's cash position was £642k. As a result of these initiatives, the Group's monthly overheads are expected to reduce by approximately 50 per cent. from April 2020, which will serve to extend the Company's cash runway.

The Board will continue to monitor this evolving situation and advise shareholders, as appropriate, when the impact and longevity of the COVID-19 pandemic becomes clearer.

The Company currently plans to announce its interim results for the six months ended 31 March 2020 in late May 2020.

For further information please contact:

 

i-nexus Global plc

N+1 Singer (Nominated Adviser and Broker)

Alma PR

Via: Alma PR

Tel: +44 (0)207 496 3000

Tel: +44 (0)203 405 0205

Simon Crowther, CEO

Alyson Levett, CFO

Lauren Kettle (Corporate Finance)

Tom Salvesen (Corporate Broking)

Caroline Forde

Josh Royston

 

About i-nexus Group plc

 

i-nexus supports some of the largest global companies in running, improving and changing their businesses through the provision of a scalable, enterprise-grade, cloud-based Continuous Improvement ("CI") and Strategy Execution ("SE") software platform. The platform is in use at global blue-chip businesses, predominantly based across the US and Europe, helping customers execute key strategic goals throughout all levels and divisions of their organisations.

 

The Group's software supports Hoshin Kanri, a strategy development methodology first introduced in the 1960s in Japan and born out of lean, six sigma and operational improvement theory. Hoshin Kanri (directly translated as "direction execution") is a systematic planning, implementation and review methodology which, when implemented, aims to ensure that the strategic goals of a company are properly communicated to all employees and that they drive progress and action at every level of the business.

 

i-nexus is headquartered in Coventry, UK with a sales office in New York. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFIEVAIDFII
12
Date   Source Headline
26th Feb 20245:54 pmRNSResult of AGM
26th Feb 20247:00 amRNSAGM Statement
4th Jan 20245:53 pmRNSHolding(s) in Company
20th Dec 20237:00 amRNSFinal Results
17th Oct 20237:00 amRNSCustomer Update
7th Jul 202312:34 pmRNSResult of General Meeting
21st Jun 20237:00 amRNSProposed issue of up to £0.5 million
28th Apr 20237:00 amRNSInterim Results
3rd Mar 20239:28 amRNSHolding(s) in Company
27th Feb 202311:46 amRNSResult of AGM and current trading update
20th Dec 20227:00 amRNSFinal Results
11th Nov 20222:11 pmRNSGrant of LTIP options
3rd Oct 20221:31 pmRNSGrant of LTIP options
30th Sep 20223:12 pmRNSConvertible Loan Notes Redemption Date Extension 
2nd Aug 20228:00 amRNSFurther re Board Change
30th May 20227:00 amRNSInterim Results
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
12th May 20229:54 amRNSHolding(s) in Company
6th May 20222:00 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSAppointment of CFO
28th Apr 202212:20 pmRNSHolding(s) in Company
22nd Apr 20221:52 pmRNSHolding(s) in Company
28th Feb 202212:25 pmRNSResult of AGM and Trading Update
21st Dec 20217:00 amRNSFinal Results
29th Sep 202111:10 amRNSResult of General Meeting
13th Sep 20217:00 amRNSProposed issue of up to £0.65 million
2nd Sep 20212:41 pmRNSUpdate on trading and financial position
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSInterim Results
18th May 20214:41 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
18th May 20212:05 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
20th Apr 20219:05 amRNSSecond Price Monitoring Extn
20th Apr 20219:00 amRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSHolding(s) in Company
20th Apr 20217:00 amRNSStatement re Share Price Movement
19th Apr 20214:40 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20212:00 pmRNSPrice Monitoring Extension
16th Apr 20219:05 amRNSSecond Price Monitoring Extn
16th Apr 20219:00 amRNSPrice Monitoring Extension
29th Mar 20213:14 pmRNSDirector/PDMR Shareholding
25th Mar 20214:18 pmRNSResult of AGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.